Status and phase
Conditions
Treatments
About
Open-Label, multiple-dose, drug interaction study to assess the effect of nevirapine on the pharmacokinetics of atazanavir in HIV-infected individuals.
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
46 participants in 4 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal